CAFC

17-2374

Forest Laboratories Holdings v. Hikma Pharmaceuticals

General

Filed08/02/17

Appeal FromD. Delaware

Originating Case1:14-cv-01119

Decision03/14/19

Appeal OutcomeAppellant

Judges

Judge	Cases	PO Affirm Rate	Ch Affirm Rate
Sharon Prost	1000+	76%	37%
Timothy B. Dyk	1000+	76%	42%
Kimberly Ann Moore	1000+	71%	35%

Appellant

Party

Name	Ratings
Hikma Pharmaceuticals USA Inc	---- --
Hikma Pharmaceuticals PLC	---- --
Hikma Pharmaceuticals LLC	---- --
Amneal Pharmaceuticals Of New York LLC	L4E
Amneal Pharmaceuticals LLC	L4E
Amneal Pharmaceuticals Co India Pvt Ltd	L4E
Alembic Pharmaceuticals Ltd	L2D
Alembic Pharmaceuticals Inc	L2D
Alembic Global Holding SA	L2D
Breckenridge Pharmaceutical Inc	L2E

Attorney

Name	Ratings
Simon Law Firm	L5A
Anthony G. Simon	L4E
Anthony Re Friedman	---- --
Hunton & Williams LLP	L4D
Ksenia Takhistova	---- --
Kelley Drye & Warren LLP	L2C
Clifford Katz	---- --
Malavika Rao	---- --
Sughrue Mion PLLC	L1D
Michael R. Dzwonczyk	---- --
Schiff Hardin LLP	L1E
Imron T. Aly	L2D
Joel M. Wallace	---- --
Young Conaway Stargatt & Taylor LLP	---- --
Karen L. Pascale	---- --

Appellee

Party

Name	Ratings
Forest Laboratories Holdings Ltd	L5E
Forest Laboratories LLC	L5E
Sigmapharm Laboratories LLC	L1D

Attorney

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5A
Charles E. Lipsey	L5A
Sanya Sukduang	---- --
Howard W. Levine	---- --
Jonathan R. Davies	---- --
Simon Law Firm	L5A
Anthony G. Simon	L4E
Anthony Re Friedman	---- --
Morris Nichols Arsht & Tunnell LLP	L2E
Jack B. Blumenfeld	L4A